|
|
|
|
| LEADER |
00000cam a22000004a 4500 |
| 001 |
6638546 |
| 003 |
ICU |
| 005 |
20080506201800.0 |
| 008 |
061204s2007 njua b 001 0 eng |
| 010 |
|
|
|a 2006100243
|
| 020 |
|
|
|a 9780471739074 (cloth)
|
| 020 |
|
|
|a 0471739073 (cloth)
|
| 035 |
|
|
|a 2006100243
|
| 035 |
|
|
|a (OCoLC)76967166
|
| 040 |
|
|
|a DNLM/DLC
|c DLC
|d BTCTA
|d NLM
|d BAKER
|d UKM
|d C#P
|d YDXCP
|d UtOrBLW
|
| 042 |
|
|
|a pcc
|
| 050 |
0 |
0 |
|a QR189
|b .V232 2007
|
| 060 |
0 |
0 |
|a 2007 I-035
|
| 060 |
1 |
0 |
|a QW 805
|b V115 2007
|
| 082 |
0 |
0 |
|a 615/.372
|2 22
|
| 245 |
0 |
0 |
|a Vaccine adjuvants and delivery systems /
|c edited by Manmohan Singh.
|
| 260 |
|
|
|a Hoboken, N.J. :
|b Wiley-Interscience,
|c c2007.
|
| 300 |
|
|
|a x, 449 p. :
|b ill. ;
|c 25 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Development of vaccine adjuvants : a historical perspective / Gary Ott and Gary Van Nest -- Antigen processing and presentation / Subash Sad -- Mechanisms of adjuvant action / Nils Lycke -- Aluminum-containing adjuvants : properties, formulation, and use / Stanley L. Hem and Harm HogenEsch -- MF59 : a safe and potent oil-in-water emulsion adjuvant / Derek T. O'Hagan and Manmohan Singh -- TLR4 agonists as vaccine adjuvants / David A. Johnson and Jory R. Baldridge -- Immunostimulatory CpG oligodeoxynucleotides as vaccine adjuvants / Dennis M. Klinman, Debbie Currie, and Hidekazu Shirota -- Small molecule immunopotentiators as vaccine adjuvants / Fengfeng Xu, Nicholas M. Valiante, and Jeffrey B. Ulmer -- New ISCOMs meet unsettled vaccine demands / Bror Morein ... [et al.] -- Surface-charged poly(lactide-co-glycolide) microparticles as novel antigen delivery systems / Manmohan Singh ... [et al.] -- Liposomal cytokines and liposomes targeted to co-stimulatory molecules as adjuvants for HIV subunit vaccines / Bulent Ozpolat and Lawrence B. Lachman -- Archaeosome vaccine adjuvants for cross-priming CD8+ T-cell immunity / Lakshmi Krishnan and G. Dennis Sprott -- Mucosal adjuvants and delivery systems / Michael Vajdy -- Cytokines as vaccine adjuvants / Nejat K. Egilmez -- Polyphosphazenes as vaccine adjuvants / Alexander K. Andrianov -- Vaccine delivery by transdermal electroporation / Amit Misra -- Nonclinical safety assessment of vaccines and the evaluation of novel adjuvants and delivery systems / Jose A. Lebron ... [et al.] -- Safety evaluation of vaccine adjuvants / Erik B. Lindblad.
|
| 650 |
|
0 |
|a Vaccines.
|0 http://id.loc.gov/authorities/subjects/sh85141718
|
| 650 |
|
0 |
|a Immunological adjuvants.
|0 http://id.loc.gov/authorities/subjects/sh85000895
|
| 650 |
1 |
2 |
|a Vaccines
|x administration & dosage.
|
| 650 |
2 |
2 |
|a Adjuvants, Immunologic
|x administration & dosage.
|
| 650 |
2 |
2 |
|a Drug Delivery Systems
|x methods.
|
| 650 |
|
7 |
|a Immunological adjuvants.
|2 fast
|0 http://id.worldcat.org/fast/fst00967992
|
| 650 |
|
7 |
|a Vaccines.
|2 fast
|0 http://id.worldcat.org/fast/fst01163573
|
| 700 |
0 |
|
|a Manmohan Singh,
|d 1964 November 8-
|0 http://id.loc.gov/authorities/names/n2006185418
|1 http://viaf.org/viaf/44621756
|
| 903 |
|
|
|a HeVa
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i 0791231a-5f8b-53e2-8795-91dc0d0caec2
|s 83b5457b-7976-5a99-b063-831f2f1dcb7d
|
| 928 |
|
|
|t Library of Congress classification
|a QR189 .V232 2007
|l JCL
|c JCL-Sci
|i 5158095
|
| 927 |
|
|
|t Library of Congress classification
|a QR189 .V232 2007
|l JCL
|c JCL-Sci
|e VAND
|e CRERAR
|b 80470844
|i 8291463
|
